US court invalidates key patent on J&J’s Zytiga
J&J to appeal decision.
X
US court invalidates key patent on J&J’s Zytiga
https://pharmaphorum.com/news/court-invalidates-key-patent-jjs-zytiga/
litigation
Concordia hiked drug price by 6,000%, says UK watchdog
CMA provisionally finds Concordia overpriced thyroid drug.
Judge throws out Allergan patents, criticises Native American tribe deal
Federal court throws out patents on Restasis
US lawmaker moves to block Allergan patent deal with tribe
Senator Claire McCaskill says deal exploits a “brazen loophole”.
Native American tribe open to more patent deals with pharma
Saint Regis Mohawk Tribe expects more interest from pharma after Allergan deal.
J&J to pay $417m in talc cancer case
J&J to appeal California court’s verdict
Mylan finalises $465m deal with US government over EpiPen
Mylan finalises rebate deal with US government.
EU authorities accuse Teva of breaking competition rules
Teva accused of “pay for delay” deal with Cephalon.
Shire injunction blocks Roche’s ‘misleading’ statements on haemophilia drugs
Shire alleges trial info “unlawfully disparages” its product.